Highlights from SABCS 2021

Seattle, WA US
January 29, 2022

OUR CONFERENCE WILL PROVIDE RAPID ANTIGEN COVID19 TESTING FOR ALL ATTENDEES AND FACULTY.

Management of breast cancer is rapidly evolving. A number of potentially practice-changing abstracts are expected to be presented during the 2021 San Antonio Breast Cancer Symposium (SABCS 2021) in December, 2021. At this in-person oncology conference held in Seattle,  Highlights from SABCS 2021, expert faculty will place abstract findings from the SABCS 2021 annual meeting into clinical context and discuss how the results may change the current standard of care for breast cancer patients. 

Target Audience

  • Medical oncologists
  • Radiation oncologists
  • Surgical oncologists
  • Oncology residents/fellows
  • Oncology NPs/PAs
  • Oncology pharmacists
  • Oncology nurses 

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Identify the role of novel molecular abnormalities, prognostic markers and risk factors in breast cancer pathogenesis, risk of recurrences and their implications on breast cancer prevention and management.
  • Review data presented at the 2021 San Antonio Breast Cancer Symposium and discuss their application in clinical settings 
  • Discuss the study design and primary endpoints of recently reported and ongoing clinical trials evaluating novel strategies for the management of breast cancer
  • Compare and contrast the safety and efficacy profiles of novel therapeutic strategies that impact breast cancer management
  • Integrate emerging evidence into treatment paradigms for treatment of patients with breast cancer
Course summary
Available credit: 
  • 6.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 6.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 0.00 Attendance
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.
Course opens: 
10/07/2021
Course expires: 
02/28/2022
Event starts: 
01/29/2022 - 7:00am PST
Event ends: 
01/29/2022 - 4:00pm PST
Cost:
$1.00

Conference Chair: Fengting Yan, MD, PhD

All times listed below are in Pacific Standard Time.


08:00 – 08:10 AM PST: Opening remarks - Nancy E. Davidson, MD


Moderator: Shaveta Vinayak, MD, MS 

08:10 – 08:40 AM PST: Advances and controversies in DCIS and locoregional invasive disease - Christos Vaklavas, MD 

08:40 – 09:10 AM PST: Prevention, survivorship, and healthcare delivery - Poorni Manohar, MD 

09:10 – 09:40 AM PST: Genetic and other biomarkers for prognosis and prediction of systemic therapy - Siddhartha Yadav, MBBS, MD


09:40 – 10:00 AM PST: Break


Moderator: Shaveta Vinayak, MD, MS

10:00 – 10:30 AM PST: Novel targets and therapeutics for early and advanced ER+ disease - Natasha Hunter, MD

10:30 – 11:00 AM PST: Advances in approaches to triple-negative breast cancer - Hope S. Rugo, MD

11:00 – 12:00 PM PST: Case-based discussion - Nanette Robinson, MD


12:00 – 01:00 PM PST: Lunch


Moderator: William R Gwin III, MD 

01:00 – 01:30 PM PST: Updates in Radiation oncology - Janice Kim, MD

01:30 – 02:00 PM PST: Updates in Breast surgery - Sara H. Javid, MD

02:00 – 02:30 PM PST: HER2+ updates and leads for the future – (Neo)/Adjuvant and advanced settings - Jennifer M. Specht, MD

02:30 – 03:30 PM PST: Case-based discussion - Fengting Yan, MD, PhD


3:30PM PST: Adjourn

Grand Hyatt Seattle
721 Pine St
Seattle, WA 98101
United States

A limited number of rooms have been reserved at the Grand Hyatt Seattle for the Highlights from SABCS attendees at a single occupancy rate of $169/night exclusive of all taxes and fees. Please follow the link below to book your hotel room.

Click here to be redirected to the hotel's group booking site for this oncology conference.

Grand Hyatt Seattle is located in the heart of downtown Seattle’s Theater District, within walking distance to the waterfront, Pike Place Market, and just 25 minutes to Sea-Tac Airport, with convenient parking options on-site.

 

Travel

Parking

Leave your vehicle in a secure public garage, attached to the hotel and explore downtown Seattle by foot. Grand Hyatt Seattle is pleased to offer self-parking for your convenience.

*Parking is subject to availability and pricing may change

Self Parking: $37 /Overnight. Available at Meridian Parking Garage, no in/out privileges. Fully payable to the garage.

Valet Parking: $55 /Overnight

Other Transportation

Getting to Grand Hyatt Seattle is now easier and greener than ever with the Seattle Link Light rail train. The train will take you directly from Sea-Tac Airport to the Westlake Light Rail station, two blocks from the Grand Hyatt, for only $3 each way. 

Amtrak Train King Street Station: 1.5 miles
Greyhound Bus: 2.5 miles
Boeing Field King County International Airport: 6.5 miles
Sea-Tac Airport: 14 miles
 

 

 

No members of this activity's planning committee or faculty have any relevant financial relationship with an ineligible entity except for the following faculties:

Moderator(s)

Shaveta Vinayak, MD, MS

has a financial relationship (Grant Or Contract) with Seattle Genetics;.
has a financial relationship (Grant Or Contract) with Pfizer;.
has a financial relationship (Grant Or Contract) with PUMA;.
has a financial relationship (Grant Or Contract) with Oncosec;.
Speaker(s)

Nancy Davidson, MD

has no relevant financial relationships to disclose at this time.

Natasha Hunter, MD

has no relevant financial relationships to disclose at this time.

Sara Javid, MD

has no relevant financial relationships to disclose at this time.

Janice Kim, MD

has no relevant financial relationships to disclose at this time.

Poorni Manohar, MD

has no relevant financial relationships to disclose at this time.

Nanette Robinson, M.D.

has no relevant financial relationships to disclose at this time.

Hope Rugo

has a financial relationship (Grant Or Contract) with Sermonix;.
has a financial relationship (Grant Or Contract) with Ayala;.
has a financial relationship (Professional Services) with NAPO;.
has a financial relationship (Grant Or Contract) with Pfizer;.
has a financial relationship (Grant Or Contract) with Roche ;.
has a financial relationship (Grant Or Contract) with Macrogenics;.
has a financial relationship (Grant Or Contract) with AstraZeneca;.
has a financial relationship (Professional Services) with Samsung;.
has a financial relationship (Grant Or Contract) with Lilly;.
has a financial relationship (Grant Or Contract) with Polyphor;.
has a financial relationship (Professional Services) with Puma;.
has a financial relationship (Grant Or Contract) with Novartis;.
has a financial relationship (Grant Or Contract) with Seattle Genetics;.
has a financial relationship (Grant Or Contract) with Boehringer Ingelheim;.
has a financial relationship (Grant Or Contract) with Gilead;.
has a financial relationship (Grant Or Contract) with Merck;.
has a financial relationship (Grant Or Contract) with Daiichi;.

Jennifer Specht, MD

has no relevant financial relationships to disclose at this time.

Christos Vaklavas, M.D., Associate Professor

has no relevant financial relationships to disclose at this time.

Siddhartha Yadav, Siddhartha Yadav, MD, FACP

has no relevant financial relationships to disclose at this time.

Fengting Yan, MD

has no relevant financial relationships to disclose at this time.

Acknowledgment of Commercial Support

This activity has been supported with an independent medical education grant from the following companies:

  • Pfizer, Inc.

Available Credit

  • 6.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 6.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 0.00 Attendance
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.

 

 

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

Price

Cost:
$1.00
Please login or register to take this course.

Registration Fees 

Physicians (non-industry) - $200

Non-physician HPC (non-industry) - $125

Industry representatives - $650

Cancellation Policy

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is cancelled six weeks before the conference.
  • No refunds will be issued if registration is cancelled after that date.  

No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post tests as well as course evaluations.